Insights from 2023 ESMO Asia Annual Meeting

 

Insights from 2023 ESMO Asia Annual Meeting
M

ESMO Asia 2023 Insights: "IMbrave150 Trial - Exploratory Analyses for Investigating Associations Between OS and Depth of Response or Duration of Response in Patients With Unresectable HCC"

By Insights from 2023 ESMO Asia Annual Meeting FEATURING Masatoshi Kudo
By Insights from 2023 ESMO Asia Annual Meeting FEATURING Masatoshi Kudo
0 views
February 7, 2024
Comments 0
Login to view comments. Click here to Login
Gastrointestinal
18:31
Insights from 2023 ESMO Asia Annual Meeting

Enhancing IO Benefit in Upper-Aerodigestive Malignancies - Leveragin…

Feat. B. Henick
08:19
Insights from 2023 ESMO Asia Annual Meeting

Final Analysis of a Ph2 Study of Neoadjuvant S-1 + Oxaliplatin in Ol…

Feat. E. Oki
08:21
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "IMbrave150 Trial - Exploratory Analys…

Feat. M. Kudo
11:13
Insights from 2023 ESMO Asia Annual Meeting

Leveraging the Molecular Biology of HCC in Optimising Response to Im…

Feat. S. L. Chan
06:49
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Lenvatinib vs. Sorafenib 2L Therapy i…

Feat. M. Persano
06:53
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "AEs as Potential Predictive Factors o…

Feat. M. Persano
06:05
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Long-Term Outcomes of Intraoperative …

Feat. J. Taieb
21:46
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Past, Present & Future Clinical M…

Feat. M. Ikeda
18:15
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Role of IO in Gastric Cancer"

Feat. S. Rha
08:56
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "KEYNOTE-811 Study of Pembro + Trastuz…

Feat. S. Rha
13:51
Insights from 2023 ESMO Asia Annual Meeting

ESMO Asia 2023 Insights: "Final Results of the RATIONALE-305 St…

Feat. K. Kato